Journal article
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
RC Trembath, JR Thomson, RD Machado, NV Morgan, C Atkinson, I Winship, G Simonneau, N Galie, JE Loyd, M Humbert, WC Nichols, NW Morrel, J Berg, A Manes, J McGaughan, M Pauciulo, L Wheeler
New England Journal of Medicine | MASSACHUSETTS MEDICAL SOC | Published : 2001
Abstract
Background. Most patients with familial primary pulmonary hypertension have defects in the gene for bone morphogenetic protein receptor II (BMPR2), a member of the transforming growth factorβ (TGF-β) superfamily of receptors. Because patients with hereditary hemorrhagic telangiectasia may have lung disease that is indistinguishable from primary pulmonary hypertension, we investigated the genetic basis of lung disease in these patients. Methods. We evaluated members of five kindreds plus one individual patient with hereditary hemorrhagic telangiectasia and identified 10 cases of pulmonary hypertension. In the two largest families, we used microsatellite markers to test for linkage to genes en..
View full abstractGrants
Awarded by National Heart, Lung, and Blood Institute